Member Info for researcher1

I sure hope not, but did a chunky top slice at 58 just in case...

what's this? profit? and in the midst of a European war? couldn't make it up...
the only issue is whether SO will use this as his golden opportunity to sell up....

I really hope not - I want news but not leakiness....

there was a regular seller for a while too. My feeling is that it was someone preparing for Vlad the Invader. Seems to have stopped now, though of course we have market meltdown instead ....
Angle will rise over £2 at some point this H1.

bit of a hit (like all of pharma) today - thankfully the extra shares in the low 30s means no losses as yet - but that may depend on the next few days....

it worked well for me - I have two slightly red patches remaining but they are much smaller, with no raised/inflamed skin, no itching, no flaking as previously. (a touch of cosmetic and they disappear). I tried a few weeks without it to see if I was 'cured', but it began to inflame gradually, so I'm back on the sachets...

spot on Hopester - the two systems may work in combination - as with the Grail discussion we had some while ago. All assuming the Poo Tin hasn't completely sh*t on the world by then.

may I join in gawd? The two processes are not linked in any way, and the FDA de Novo is not lab-specific, but is approval for the device to be used in whichever lab acquires it. That said, I understand your thinking, in that AN has previously said that the FDA were wanting clarity on downstream analytics, and I can't see how that can be fully covered without considering a specific lab situation.

have you forgotten me already Bojo? - I finished buying earlier, pretty much propped the SP up on my own!

p.s. Angle isn't a biotech per se, just being tarred with the same brush.

I think the serious issue is Putin - biotech stocks being dumped across the board in preparation for the hit that markets will take if the tin-pot tyrant proceeds with his fiendish plan (imagine him stroking a white cat, a smirk on both their faces). The impact to Angle should be very short lived (but if you've only got 1200 shares it hardly matters).

Bojo, my nuts today were SBTX shares (quite a few, even for CFD). I bought them at 5p, so happy to let a few go. My Angle average is 59 after today (it was 57) so I'm not buying to average down!

yep, I've gone for CFD exposure today on Angle after this latest drop - the Synairgen effect I would say - so another 40K shares added. A spectrum of news incoming in the next few weeks....

well there's that maxim, and Warren Buffet's maxim, and 'he who dares wins' and 'a fool rushes in...' ad nauseam. Let Parsortix do the talking, I'd say.

whoever is selling must be kicking themselves they didn't sell when there was a strong buyer's market around 130p. I'm pleased I sold a chunk at 125, but spent it all (on a house) so can't buy back at these basement prices....

darren, there is no timeline - it is well overdue now, just depends on FDA capacity...

a very moving post dee - and precisely what many of us on here have been banging on about for a year - that the FDA, Angle and the NHS need to adopt some urgency - lives are being endangered around the world as a consequence of the delay. The very best of luck with your approach to the company, and with your health of course.

I hope everyone topped up heavily down at the bottom?!

Angle has of course jumped from 38p to near 140 recently - however it is important to remember that the FDA is important BUT is not the point - Parsortix has a world-changing role over the next decade and more, and like the US investors who got in at 60p, I bought in for a ten-fold rise - anyone who sells on (good) FDA news will, IMO, end up the biggest loser...

if FDA approval doesn't come soon it will forever be a badge of shame for them, once its impact is recognised....